A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...

UK pharm major GSK (LSE: GSK) has breached the ABPI Code of Practice for the Industry and brought discredit upon, and ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription ...

Tafinlar and Mekinist work together to slow down or stop cancer cells from growing. Omjjara will available on the PBS for the first time to treat the rare bone marrow cancer myelofibrosis in patients ...

Company's shares hit all-time high after trial success Corcept plans to file US marketing application in third quarter Drug relacorilant may get broader label than competitors, analyst says March ...

GSK's submission for the approval of Omjjara was supported by data from the pivotal MOMENTUM study and a subpopulation of adult patients with anaemia from the SIMPLIFY-1 phase III trial. MOMENTUM was ...